220 related articles for article (PubMed ID: 34968777)
1. Down-regulation of HLA-B-associated transcript 3 impairs the tumoricidal effect of natural killer cells through promoting the T cell immunoglobulin and mucin domain-containing-3 signaling in a mouse head and neck squamous cell carcinoma model.
Yang J; Xiang J; Zhu M; Zhao Y; Zhou L; Hu B; Wang C
Immunobiology; 2022 Jan; 227(1):152127. PubMed ID: 34968777
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of MLLT1 super elongation complex subunit impairs the anti-tumor activity of natural killer cells in esophageal cancer.
Liu C; Li X; Xiong F; Wang L; Chen K; Wu P; Hua L; Zhang Z
Immunobiology; 2022 Jul; 227(4):152238. PubMed ID: 35763909
[TBL] [Abstract][Full Text] [Related]
3. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion.
Rangachari M; Zhu C; Sakuishi K; Xiao S; Karman J; Chen A; Angin M; Wakeham A; Greenfield EA; Sobel RA; Okada H; McKinnon PJ; Mak TW; Addo MM; Anderson AC; Kuchroo VK
Nat Med; 2012 Sep; 18(9):1394-400. PubMed ID: 22863785
[TBL] [Abstract][Full Text] [Related]
4. Novel Effector Phenotype of Tim-3
Liu Z; McMichael EL; Shayan G; Li J; Chen K; Srivastava R; Kane LP; Lu B; Ferris RL
Clin Cancer Res; 2018 Sep; 24(18):4529-4538. PubMed ID: 29712685
[No Abstract] [Full Text] [Related]
5. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Impact of Targeting CEACAM1 in Head and Neck Squamous Cell Carcinoma.
Tam K; Schoppy DW; Shin JH; Tay JK; Moreno-Nieves U; Mundy DC; Sunwoo JB
Otolaryngol Head Neck Surg; 2018 Jul; 159(1):76-84. PubMed ID: 29436278
[TBL] [Abstract][Full Text] [Related]
7. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition.
Crist M; Yaniv B; Palackdharry S; Lehn MA; Medvedovic M; Stone T; Gulati S; Karivedu V; Borchers M; Fuhrman B; Crago A; Curry J; Martinez-Outschoorn U; Takiar V; Wise-Draper TM
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36328378
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of AT-rich interaction domain 2 underlies natural killer cell dysfunction in oral squamous cell carcinoma.
Li W; An N; Wang M; Liu X; Mei Z
Immunol Cell Biol; 2023 Jan; 101(1):78-90. PubMed ID: 36269235
[TBL] [Abstract][Full Text] [Related]
9. CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.
Wang H; Nan S; Wang Y; Xu C
J Cell Mol Med; 2021 May; 25(10):4596-4607. PubMed ID: 33733587
[TBL] [Abstract][Full Text] [Related]
10. TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer.
Zheng Y; Li Y; Lian J; Yang H; Li F; Zhao S; Qi Y; Zhang Y; Huang L
J Transl Med; 2019 May; 17(1):165. PubMed ID: 31109341
[TBL] [Abstract][Full Text] [Related]
11. Landscape of natural killer cell activity in head and neck squamous cell carcinoma.
Charap AJ; Enokida T; Brody R; Sfakianos J; Miles B; Bhardwaj N; Horowitz A
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33428584
[TBL] [Abstract][Full Text] [Related]
12. Sirtuin 2 up-regulation suppresses the anti-tumour activity of exhausted natural killer cells in mesenteric lymph nodes in murine colorectal carcinoma.
Jiang B; Ke C; Zhou H; Xia T; Xie X; Xu H
Scand J Immunol; 2023 Nov; 98(5):e13317. PubMed ID: 38441393
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of natural killer cell therapy combined with chemoradiotherapy in murine models of head and neck squamous cell carcinoma.
Jung EK; Chu TH; Kim SA; Vo MC; Nguyen VT; Lee KH; Jung SH; Yoon M; Cho D; Lee JJ; Yoon TM
Cytotherapy; 2024 Mar; 26(3):242-251. PubMed ID: 38142382
[TBL] [Abstract][Full Text] [Related]
14. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer.
Liu L; Lim MA; Jung SN; Oh C; Won HR; Jin YL; Piao Y; Kim HJ; Chang JW; Koo BS
Phytomedicine; 2021 Nov; 92():153758. PubMed ID: 34592487
[TBL] [Abstract][Full Text] [Related]
15. A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis.
Saresella M; Piancone F; Marventano I; La Rosa F; Tortorella P; Caputo D; Rovaris M; Clerici M
FASEB J; 2014 Nov; 28(11):5000-9. PubMed ID: 25091272
[TBL] [Abstract][Full Text] [Related]
16. IFNalpha2b stimulated release of IFNgamma differentially regulates T cell and NK cell mediated tumor cell cytotoxicity.
Bose A; Baral R
Immunol Lett; 2007 Jan; 108(1):68-77. PubMed ID: 17112599
[TBL] [Abstract][Full Text] [Related]
17. Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells.
Bhattacharya S; Muhammad N; Steele R; Kornbluth J; Ray RB
Cancer Prev Res (Phila); 2017 Jun; 10(6):337-344. PubMed ID: 28465362
[TBL] [Abstract][Full Text] [Related]
18. Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma.
Faden DL; Concha-Benavente F; Chakka AB; McMichael EL; Chandran U; Ferris RL
Head Neck; 2019 Aug; 41(8):2591-2601. PubMed ID: 30828910
[TBL] [Abstract][Full Text] [Related]
19. Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines.
Lee J; Keam B; Park HR; Park JE; Kim S; Kim M; Kim TM; Kim DW; Heo DS
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5705-5715. PubMed ID: 36547689
[TBL] [Abstract][Full Text] [Related]
20. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]